Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Urogenital Neoplasms 2Colitis 2Carcinoma, Non-Small-Cell Lung 2Takayasu Arteritis 1Melanoma 1Lung Neoplasms 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1

Interventions

Educational Status 2vedolizumab 1Vitamin E 1Vaccines 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Standard of Care 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Proctocolectomy, Restorative 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Photoplethysmography 1Phlebotomy 1Papillomavirus Vaccines 1Nivolumab 1Methods 1Lysine Acetyltransferase 5 1Laparoscopy 1Iron-Dextran Complex 1Interviews as Topic 1Infliximab 1Indigo Carmine 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Herpes Zoster Vaccine 1Fish Oils 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Crohn Disease × CT-P13 × Clear all
NCT04646187 2025-01-06

FREE

University Medical Center Groningen

Phase 4 Enrolling by invitation
148 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡